We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Genetic Screening May Predict Risk of CMV Infection

By LabMedica International staff writers
Posted on 10 Jan 2017
Print article
Image: A ribbon model illustration of the nucleotide-binding oligomerization domain 1 (NOD1) protein. Researchers have found that a genetic mutation that alters NOD1 structure may increase susceptibility to human cytomegalovirus (Image courtesy of Wikimedia).
Image: A ribbon model illustration of the nucleotide-binding oligomerization domain 1 (NOD1) protein. Researchers have found that a genetic mutation that alters NOD1 structure may increase susceptibility to human cytomegalovirus (Image courtesy of Wikimedia).
Researchers have found that the protein nucleotide-binding oligomerization domain 1 (NOD1) is involved in regulating cytomegalovirus (CMV) infection and that loss-of-function NOD1 variants may result in higher susceptibility to CMV infection, which can lead to devastating developmental defects in fetuses and severe disease in people with weakened immune systems.

The new study, led by researchers Johns Hopkins University School of Medicine (Baltimore, MD, USA), provides what appears to be the first reported evidence that NOD1, a protein with a well-known role in inducing the innate immune response, has an integral role in control of CMV and that certain NOD1 variants may increase risk of susceptibility.

CMV is transmitted from person to person through body fluids. Most people show no signs or symptoms of infection, while others develop symptoms such as a fever, sore throat, and fatigue. In addition, CMV causes colitis in individuals with Crohn’s disease and patients with suppressed immune systems, making it a significant risk to transplant recipients.

Furthermore, CMV has not drawn the same attention in the medical and scientific community as the much less common Zika virus, despite causing similar neurological complications, said Prof. Boger. According to the US Centers for Disease Control and Prevention (CDC), 1 in 150 babies in the US is born with a congenital CMV infection, and of those, 1 in 5 suffers from complications, which can include hearing loss, vision loss, cerebral palsy, cognitive impairments, and microcephaly.

“Our results suggest that this protein explains why not every person is at the same risk for CMV, and that we might someday be able to develop tests to identify and manage those who are at an increased risk for CMV-related disease,” said Ravit Boger, MD, associate professor at Johns Hopkins medical schoo. Building upon previous research in which Prof. Boger’s team identified NOD2 as a protein that controls CMV infection, its sister molecule NOD1 was found in the new study to also be important. “We do not yet know how NOD1 accomplishes this function, or if NOD1 and NOD2 coordinate or work independently in the control of CMV,” said Prof. Boger.

Using human fibroblasts that make up connective tissue, the team tested whether NOD1 activity could affect CMV replication in the cultured cells. They upregulated NOD1 by treating the cells with a bacterial fragment. They also tested genetically engineered cells that contain nonfunctional NOD1. The results showed that cells in which NOD1 was activated had decreased levels of CMV replication compared to controls.

In mouse experiments, the researchers treated the animals with two doses of iE-DAP, another bacterial NOD1 activator, and subsequently infected them with mouse CMV. Two weeks later, organs and intracardiac blood were collected from the mice and cells were cultured. The cultured cells were monitored for areas of cell death as an indicator of viral activity. Compared to untreated control mice, virus replication in iE-DAP-treated mice was significantly reduced.

How mutations in NOD1 protein determine its function against CMV remains to be determined. Prof. Boger cautions that NOD1 is not the only factor in determining risk of CMV infection, rather it is one piece of a larger puzzle in determining risk. The team will now investigate the cell signaling pathways involving the NOD proteins to help pin down how NOD1 and NOD2 interact with CMV.

The study, by Fan YH et al, was published November 14, 2016, in the journal Proceedings of the National Academy of Science (PNAS).

Related Links:
Johns Hopkins University School of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.